Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,708 | 23 | 92.6% |
| Education | $137.52 | 4 | 7.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $566.75 | 9 | $0 (2024) |
| Pulmonx Corporation | $288.89 | 2 | $0 (2024) |
| United Therapeutics Corporation | $147.82 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $130.46 | 1 | $0 (2023) |
| Merck Sharp & Dohme LLC | $122.88 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $120.00 | 1 | $0 (2018) |
| HARMONY BIOSCIENCES LLC | $112.52 | 1 | $0 (2024) |
| Genentech USA, Inc. | $99.99 | 1 | $0 (2019) |
| Pharming Healthcare, Inc. | $95.43 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $66.57 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $702.33 | 6 | United Therapeutics Corporation ($147.82) |
| 2023 | $506.26 | 5 | Pulmonx Corporation ($142.56) |
| 2021 | $99.73 | 4 | AstraZeneca Pharmaceuticals LP ($78.85) |
| 2019 | $241.49 | 3 | AstraZeneca Pharmaceuticals LP ($111.75) |
| 2018 | $237.55 | 3 | Regeneron Healthcare Solutions, Inc. ($120.00) |
| 2017 | $58.61 | 6 | GlaxoSmithKline, LLC. ($25.02) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $50.72 | General |
| Category: Neurology | ||||||
| 10/08/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $146.33 | General |
| Category: PULMONOLOGY | ||||||
| 10/07/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | Cash or cash equivalent | $147.82 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 06/27/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $112.52 | General |
| Category: Narcoplepsy | ||||||
| 04/03/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $122.88 | General |
| Category: ONCOLOGY | ||||||
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $122.06 | General |
| Category: Respiratory | ||||||
| 10/10/2023 | Pharming Healthcare, Inc. | JOENJA (Drug) | Food and Beverage | In-kind items and services | $95.43 | General |
| Category: APDS | ||||||
| 10/10/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $60.53 | General |
| Category: Oncology | ||||||
| 10/09/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $77.28 | General |
| Category: Respiratory | ||||||
| 09/26/2023 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $142.56 | General |
| Category: PULMONOLOGY | ||||||
| 06/27/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $130.46 | General |
| Category: RESPIRATORY | ||||||
| 10/27/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 10/21/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $51.84 | General |
| Category: Respiratory | ||||||
| 03/12/2021 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $20.88 | General |
| Category: HFCWO | ||||||
| 01/27/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $15.45 | General |
| Category: Respiratory | ||||||
| 10/22/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: RESPIRATORY | ||||||
| 10/19/2019 | Genentech USA, Inc. | Esbriet (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 06/12/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $111.75 | General |
| Category: Respiratory | ||||||
| 12/17/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/01/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $105.75 | General |
| Category: Respiratory | ||||||
| 02/16/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2017 | GlaxoSmithKline, LLC. | — | Education | In-kind items and services | $10.52 | General |
| 12/04/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: RESPIRATORY | ||||||
| 12/01/2017 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $10.53 | General |
| 09/22/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 523 | 598 | $117,888 | $39,089 |
| 2022 | 13 | 518 | 612 | $102,023 | $39,682 |
| 2021 | 16 | 621 | 721 | $114,432 | $47,669 |
| 2020 | 18 | 927 | 1,113 | $171,082 | $62,384 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 141 | 182 | $42,146 | $16,208 | 38.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 59 | 67 | $21,605 | $8,699 | 40.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $11,377 | $3,942 | 34.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $6,840 | $2,038 | 29.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 38 | 42 | $4,410 | $1,789 | 40.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 70 | 76 | $5,244 | $1,546 | 29.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 35 | 39 | $4,602 | $1,108 | 24.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 58 | 65 | $2,080 | $1,074 | 51.6% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 22 | 22 | $15,202 | $888.33 | 5.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 23 | 24 | $1,968 | $813.12 | 41.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 16 | 18 | $1,836 | $750.10 | 40.9% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 15 | 17 | $578.00 | $231.68 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 150 | 196 | $41,995 | $18,388 | 43.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $17,363 | $5,758 | 33.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 40 | $12,248 | $5,286 | 43.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $5,073 | $1,872 | 36.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 71 | 88 | $6,072 | $1,694 | 27.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 31 | 36 | $3,780 | $1,523 | 40.3% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 61 | 71 | $2,272 | $1,163 | 51.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 30 | 32 | $3,776 | $860.77 | 22.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 12 | 12 | $2,628 | $811.70 | 30.9% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 23 | 23 | $2,990 | $746.88 | 25.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 17 | 18 | $1,836 | $722.29 | 39.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 17 | 18 | $1,476 | $612.66 | 41.5% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 13 | 16 | $514.00 | $242.83 | 47.2% |
About Dr. Michael Nakao, MD
Dr. Michael Nakao, MD is a Pulmonary Disease healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1538169404.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Nakao, MD has received a total of $1,846 in payments from pharmaceutical and medical device companies, with $702.33 received in 2024. These payments were reported across 27 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,708).
As a Medicare-enrolled provider, Nakao has provided services to 2,589 Medicare beneficiaries, totaling 3,044 services with total Medicare billing of $188,823. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Albany, NY
- Active Since 07/21/2005
- Last Updated 05/19/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1538169404
Products in Payments
- CHARTIS CATHETER (Device) $288.89
- FASENRA (Drug) $217.50
- FASENRA (Biological) $199.34
- TYVASO (Drug) $147.82
- OFEV (Drug) $130.46
- KEYTRUDA (Biological) $122.88
- DUPIXENT DUPILUMAB INJECTION (Biological) $120.00
- WAKIX (Drug) $112.52
- Esbriet (Biological) $99.99
- JOENJA (Drug) $95.43
- BREZTRI (Drug) $78.85
- IMFINZI (Biological) $60.53
- Sunosi (Drug) $50.72
- NUCALA (Biological) $41.55
- BROVANA (Drug) $23.06
- SMARTVEST (Device) $20.88
- BREO (Drug) $14.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Albany
Dr. Boris Shkolnik, M.d, M.D
Pulmonary Disease — Payments: $157,608
Jyotir Mehta, Md, MD
Pulmonary Disease — Payments: $13,328
Dr. Vadim Divilov, Md, MD
Pulmonary Disease — Payments: $7,276
Daniel Greenberg, Do, DO
Pulmonary Disease — Payments: $5,867
Dr. Mark Napier, M.d, M.D
Pulmonary Disease — Payments: $4,614
Dennis Gort, Md, MD
Pulmonary Disease — Payments: $1,046